Active
Overview
- Legal name
- GENENTECH INC
- Registered location
- SOUTH SAN FRANCISCO, CA, USA
- Website
- Company website ↗
- Primary NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- Latest award activity
- Jul 29, 2026
Read company summary
GENENTECH INC is associated with UEI F7F8GZXL7Q93 and CAGE 1HZ12 in public federal records. AcornBids currently links 2 prime awards totaling $252.8M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325412 (Pharmaceutical Preparation Manufacturing). Its public SAM.gov registration lists SOUTH SAN FRANCISCO, CA, USA.
At a glance
Lifetime prime obligations$252.8M
Prime awards2
Awards with future end dates1
Top-agency concentration
Not available
Why this customer concentration
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 27, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- GENENTECH INC
- UEI
- F7F8GZXL7Q93
- CAGE
- 1HZ12
- Registered address
- 1, DNA WAY, SOUTH SAN FRANCISCO, CA, 94080, USA
- Registration status
- Active
- Primary NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- SAM activation
- Mar 19, 2026
- Initial registration
- May 7, 2001
- Entity start
- Dec 23, 1986
- SAM updated
- Mar 19, 2026
- Registration expires
- Mar 17, 2027
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75A50118D00036ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA | Department of Health and Human Services | $251.7M | Sep 27, 2018 | Not available |
| 75F40125C00069THIS PROJECT FOCUSES ON ADDRESSING CRITICAL CHALLENGES IN THE DESIGN AND ANALYSIS OF HYBRID RANDOMIZED CONTROLLED TRIALS (RCTS) IN LONGITUDINAL SETTINGS. THE FIRST GOAL IS TO… | Department of Health and Human Services | $1.1M | Sep 11, 2025 | Mar 29, 2030 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Mar 19, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | May 7, 2001 |
| Entity start | Dec 23, 1986 |
| Industry | Reported size status |
|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| JILL SHOTZBERGER | Government business | Contact method not published | SAM registration | Not available |
| JOSEPH BERRYHILL | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325412 — Pharmaceutical Preparation Manufacturing
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
49 awards
26 awards
25 awards
20 awards
18 awards
16 awards
15 awards
About GENENTECH INC
What products and services appear in its federal awards?
Recorded award industries: 541714 — Research and Development in Biotechnology (except Nanobiotechnology).
Recorded products and services: AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT; AJ11 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH.
Examples from recent award records:
- ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA
- THIS PROJECT FOCUSES ON ADDRESSING CRITICAL CHALLENGES IN THE DESIGN AND ANALYSIS OF HYBRID RANDOMIZED CONTROLLED TRIALS (RCTS) IN LONGITUDINAL SETTINGS. THE FIRST GOAL IS TO…
These records describe federal award work, not every company capability. Review the award evidence.
Where is the company registered?
1, DNA WAY, SOUTH SAN FRANCISCO, California 94080, United States
Registered location from SAM.gov; award performance locations may differ.
What is its primary registered industry?
325412 — Pharmaceutical Preparation Manufacturing.
Primary SAM.gov NAICS classification.
Which federal agencies are represented in its awards?
Department of Health and Human Services.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit